Orchid Pharma Statistics

Total Valuation

Orchid Pharma has a market cap or net worth of INR 70.31 billion. The enterprise value is 71.63 billion.

Market Cap	70.31B
Enterprise Value	71.63B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Orchid Pharma has 50.72 million shares outstanding. The number of shares has increased by 11.55% in one year.

Shares Outstanding	50.72M
Shares Change (YoY)	+11.55%
Shares Change (QoQ)	+4.75%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	23.31%
Float	15.19M

Valuation Ratios

The trailing PE ratio is 59.76 and the forward PE ratio is 43.77. Orchid Pharma's PEG ratio is 1.09.

PE Ratio	59.76
Forward PE	43.77
PS Ratio	7.61
PB Ratio	6.01
P/FCF Ratio	n/a
PEG Ratio	1.09

Financial Ratio History

Enterprise Valuation

EV / Earnings	63.89
EV / Sales	8.13
EV / EBITDA	63.31
EV / EBIT	82.53
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.12
Debt / EBITDA	1.19
Debt / FCF	n/a
Interest Coverage	6.10

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	4.69%
Revenue Per Employee	10.11M
Profits Per Employee	1.29M
Employee Count	871
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +170.38% in the last 52 weeks. The beta is 2.08, so Orchid Pharma's price volatility has been higher than the market average.

Beta (5Y)	2.08
52-Week Price Change	+170.38%
50-Day Moving Average	1,410.14
200-Day Moving Average	1,124.27
Relative Strength Index (RSI)	50.88
Average Volume (20 Days)	87,276

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orchid Pharma had revenue of INR 8.81 billion and earned 1.12 billion in profits. Earnings per share was 23.20.

Revenue	8.81B
Gross Profit	3.39B
Operating Income	872.39M
Pretax Income	1.09B
Net Income	1.12B
EBITDA	1.13B
EBIT	872.39M
Earnings Per Share (EPS)	23.20

Full Income Statement

Balance Sheet

The company has 36.16 million in cash and 1.35 billion in debt, giving a net cash position of -1.32 billion or -25.94 per share.

Cash & Cash Equivalents	36.16M
Total Debt	1.35B
Net Cash	-1.32B
Net Cash Per Share	-25.94
Equity (Book Value)	11.69B
Book Value Per Share	230.58
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 38.54%, with operating and profit margins of 9.90% and 12.73%.

Gross Margin	38.54%
Operating Margin	9.90%
Pretax Margin	12.36%
Profit Margin	12.73%
EBITDA Margin	12.86%
EBIT Margin	9.90%
FCF Margin	n/a

Dividends & Yields

Orchid Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.55%
Shareholder Yield	-11.55%
Earnings Yield	1.67%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a